Tue, October 3, 2023
Mon, October 2, 2023
Sun, October 1, 2023
Fri, September 29, 2023
Thu, September 28, 2023
Wed, September 27, 2023
Tue, September 26, 2023

Laura Chico Reiterated (TVTX) at Buy and Held Target at $12 on, Sep 29th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-12-on-sep-29th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Laura Chico of Wedbush, Reiterated "Travere Therapeutics, Inc." (TVTX) at Buy and Held Target at $12 on, Sep 29th, 2023.

Laura has made no other calls on TVTX in the last 4 months.



There are 10 other peers that have a rating on TVTX. Out of the 10 peers that are also analyzing TVTX, 3 agree with Laura's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Mohit Bansal of "Wells Fargo" Downgraded from Buy to Hold and Decreased Target to $8 on, Friday, September 22nd, 2023
  • Tim Lugo of "William Blair" Downgraded from Buy to Hold on, Thursday, September 21st, 2023
  • Nicole Gabreski of "Piper Sandler" Maintained at Hold with Decreased Target to $19 on, Friday, August 18th, 2023


These are the ratings of the 7 analyists that currently disagree with Laura


  • Greg Harrison of "B of A Securities" Maintained at Strong Buy with Decreased Target to $27 on, Friday, September 22nd, 2023
  • Liisa Bayko of "Evercore ISI Group" Maintained at Buy with Decreased Target to $14 on, Friday, September 22nd, 2023
  • Carter Gould of "Barclays" Maintained at Buy with Decreased Target to $12 on, Friday, September 22nd, 2023
  • Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $18 on, Friday, September 22nd, 2023
  • Vamil Divan of "Guggenheim" Maintained at Strong Buy with Decreased Target to $18 on, Friday, September 22nd, 2023
  • Anupam Rama of "JP Morgan" Initiated at Buy and Held Target at $26 on, Friday, July 21st, 2023
  • Edward Nash of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $35 on, Tuesday, July 18th, 2023

Publication Contributing Sources